• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/5

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

5 Cards in this Set

  • Front
  • Back
Interstitial Lung disease(nofc:by VP)
CXR is starting point for diagnosis. Widespread changes, involving both lung fields, though not equally.

HX impt- dusts, chem., occup.Hx, Drugs (cytoxic, penicllin, gold, amiodarone), radiation, illnesses esp collagen vascular dz’s
Sx Hx: most common breathlessness and dry cough (stretch R), review old CXR’s, rales, clubbing, exercise desturation

PFT: restrictive pattern, ßDLCO

· Diffuse thickened alv walls by inflamm, edema and/or fibrosis
· CXR- interstitial changes, HresCT-suggest area for biopsy
· Bronchoscopy- deseases whose histological characteristics can be seen on small specimens
· BAL- infxns: PCP, inflamm cell type
· Dx by transbronchial or open/thorcoscopic wedge biopsy (perform in active disease areas)
· Ddx include asbestosis, silicosis, drugs, farmer’s lung, TB, IPF, collagen vasc. Dz, pulmonary vasculitis, and sarcoidosis, etc.
Idiopathic Pulmonary Fibrosis
· Cryptogenic fibrosing alveolitis
· 50 yo onset; 5 year mortality = 50%
· progr pulm involvement w/cyanosis, cor pulmonale and respiratory failure; coarse linear densities with peripheral honeycomb pattern
· Bibasilar end inspiratory crackles/rales- when alveoli open at the end of inspiration
· Risks: Smoking, exp to wood/metal dust
· Dx of exclusion
· trt w/xplant, but immunosup. Good but objective responses in < 50%
· UIP = IPFà usual interstitial pneumonia
· AIP or Hamman- Rich Syndrome – rapid course; slower than infection but faster than IPF
Major clinical criteria for IPF:
· Exclusion of othr causes (RA), abnl PFT’s, bibasilar reticular abnls, ground glass opacities, have to have transbronchial biopsy or BAL with no features supporting alternative diagnosis
· Age >50 yrs, insidious onset with DOE, duration >3mos, bibasilar inpiratory crackles
Risk factors
· Cigarettes, metal dust, wood dust, viruses, hered.
Collagen Vascular Diseases
· Differ from IPF b/c part of multisys. dz, seen prior to pulm involvement, pleural involvement common
1. SLE
· Pleuritis/pleural effusion (common with coll vasc dz assoc w/ILD); occ, severe acute lupus pneumonitis, fibrosis less common, alveolar hem.
· Diaphragmatic weakness

2. Rheumatoid Arthritis w/Pleuropulmonary Disease
· Joint dz. usually precedes pulm; M >F
· Pulm complications rare; pleural eff #1, but with IPF alone that is not common
· Other sx present: fibrosing alveolitis/IPF, necrobiotic nodules/Caplan’s syndrome (coal), bronchiolistis obliterans, associated with ILD drug toxicity (tx for RA- gold, methotrexate, etc)
3. many other vasculitides can effect the resp sys.
Sarcoidosis
· Multisystem dz of unknown etiology; lung is primary player; char by noncaseating granulomas (follow lymphatic distribution); upper 2/3 lung
· F>M; blacks>whites; usu <40 yo; Asx w/abn CXR
· Disease does not usually prog linearly; good Px
· Radiologic Stages:
0) Stage 0 – no CXR abn (sarcoid in other system)
1) Stage I – l.n. enlargement with asx and abnl CXR (KNOW most common!)
· Fungal infxn, TB, lymphoma
2) Stage II – nodes + diffuse parenchymal changes
· TB, IPF, lymphangitic CA, pneumoconiosis, PIE
3) Stage III – no nodes, diffuse changes
· Same as 2 plus berylliosis, sceloderma, alveolar proteinosis
4) Stage IV – fibrosis
· Same as stage 3
· Dx of excl, based on transbronchial biopsy + CXR bronchoscopy can make diagnosis because so diffuse
· Each stage has another diagnostic DDx that goes with it
· Half spont remit (3yrs), quarter stable, quarter progress; Systemic vital organ involvementàCNS facial n. palsy, cardiac CHF, skin, ocular-uveitis, endocrine ­Ca2+, bone cysts, lytic or sclerotic lesions; trt w/immsupp. But if asx- observe
Pneumoconioses
· Lung disease resulting from inhalation of mineral/organic dust
· Factors in dz: particle size, shape, clearance, exposure, duration of exposure, solubility, antigenicity, host factors
· Hx: get details, details of occ. Exp.miner, insulator, welder, sandblaster, foundry worker)
1) Asbestosis – WWII shipyard workers, refineries, demolition of old buildings, brake repair, insulation; irreg opacities in bilat lower lobes (plaques), calcified pleura, insidious >20 yrs, DOE, paroxysmal cough, cor pulmonale and resp failure in final states; asbestos bodies (type of Fe body – dumbbell shaped)
a) pulmonary fibrosis (asbestosis)- must have fibrosis to have asbestosis
b) benign pleural dz (adhesions/plaques)
c) bronchogenic CA – 50X Ý in smokers
d) mesothelioma – assoc w/asbestos exp but NOT w/smoking, relationship so strong get compensations, male>female
2) Silicosis – chronic, nodular “simple silicosis” most commonà fibronodular lung dz caused by LT (5 yrs) exp to crystalline silica (seen on polarized light); upper lobe, hilar adenopathy (eggshell calci); Ýrisk for TB b/c TB loves upper lobes, no Ýrisk for lung CA (asbestos does!)
a) Natural hx variable- slowly progr dyspnea, cough, sputum, may be fairly asx, most common to have CXR abnl
b) Dx: CXR and Hx, sometimes lung biop (granulomas), HRCT helpful
Hypersensitivity Pneumonitis – inhalation of/sensitivity to organic dusts; varied Ag but clinical response same, “Farmer’s lung” – moldy hay, flu-like. Dyspnea, cough, diffuse nodular, patchy consolidation, always abnl PFT’s with ¯ DLCO and PaO2, Eitology?:? thermophilic actinomycetes in moldy hay, acute change